Improvement in the prognosis of cirrhotic patients admitted to an intensive care unit, a retrospective study

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 8, 2012, Pages 897-904

  Galbois, Arnaud ^a,b,c   Trompette, Marie Laëtitia ^a   Das, Vincent ^e   Boëlle, Pierre Yves ^a,b,c   Carbonell, Nicolas ^a   Thabut, Dominique ^b,c,d   Housset, Chantal ^a,b,c   Ait Oufella, Hafid ^a,c   Offenstadt, Georges ^a,b,c   Maury, Eric ^a,b,c   Guidet, Bertrand ^a,b,c  

^a HÔPITAL SAINT ANTOINE   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e Intensive Care Unit   (France)

Author keywords

intensive care; liver cirrhosis; outcome

Indexed keywords

BILIRUBIN; CREATININE; HYPERTENSIVE FACTOR;

ACUTE KIDNEY FAILURE; ACUTE RESPIRATORY FAILURE; ADULT; ALCOHOL LIVER DISEASE; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL PERITONITIS; CLINICAL ASSESSMENT; COMA; COMORBIDITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; ESOPHAGUS VARICES BLEEDING; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; GLASGOW COMA SCALE; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HEPATITIS C; HEPATORENAL SYNDROME; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; OLIGURIA; PRIORITY JOURNAL; PROGNOSIS; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SEPSIS; SHOCK;

ADULT; AGED; END STAGE LIVER DISEASE; FEMALE; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84864056226     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283544816     Document Type: Article

References (48)

1. Aouba A, Pequignot F, Le Toullec A, Jougla E. Medical causes of death in France in 2004 and their evolution from 1980 to 2004. Bull Epidemiol Hebd Thématique 2007; 35-36:308-314.
2. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371:838-851.
3. Foreman MG, Mannino DM, Moss M. Cirrhosis as a risk factor for sepsis and death: Analysis of the National Hospital Discharge Survey. Chest 2003; 124:1016-1020.
4. Knaus WA,Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100:1619-1636.
5. Azoulay E, Pochard F, Garrouste-Orgeas M, Moreau D, Montesino L, Adrie C, et al. Decisions to forgo life-sustaining therapy in ICU patients independently predict hospital death. Intensive Care Med 2003; 29: 1895-1901.
6. Goldfarb G, Nouel O, Poynard T, Rueff B. Efficiency of respiratory assistance in cirrhotic patients with liver failure. Intensive Care Med 1983; 9:271-273.
7. Shellman RG, Fulkerson WJ, DeLong E, Piantadosi CA. Prognosis of patients with cirrhosis and chronic liver disease admitted to the medical intensive care unit. Crit Care Med 1988; 16:671-678.
8. Moreau R, Hadengue A, Soupison T, Kirstetter P, Mamzer MF, Vanjak D, et al. Septic shock in patients with cirrhosis: Hemodynamic and metabolic characteristics and intensive care unit outcome. Crit Care Med 1992; 20:746-750.
9. Castera L, Pauwels A, Levy VG. Prognostic indicators in patients with liver cirrhosis admitted to an intensive care unit. Gastroenterol Clin Biol 1996; 20:263-268.
10. Das V, Boelle PY, Galbois A, Guidet B, Maury E, Carbonell N, et al. Cirrhotic patients in the medical intensive care unit: Early prognosis and long-term survival. Crit Care Med 2010; 38:2108-2116.
11. Aggarwal A, Ong JP, Younossi ZM, Nelson DR, Hoffman-Hogg L, Arroliga AC. Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU. Chest 2001; 119:1489-1497.
12. Wehler M, Kokoska J, Reulbach U, Hahn EG, Strauss R. Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems. Hepatology 2001; 34:255-261.
13. Gildea TR, Cook WC, Nelson DR, Aggarwal A, CareyW, Younossi ZM, et al. Predictors of long-term mortality in patients with cirrhosis of the liver admitted to a medical ICU. Chest 2004; 126:1598-1603.
14. Du Cheyron D, Bouchet B, Parienti JJ, Ramakers M, Charbonneau P. The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis. Intensive Care Med 2005; 31:1693-1699.
15. Karvellas CJ, Pink F, McPhail M, Austin M, Auzinger G, Bernal W, et al. Bacteremia, acute physiology and chronic health evaluation II and modified end stage liver disease are independent predictors of mortality in critically ill nontransplanted patients with acute on chronic liver failure. Crit Care Med 2010; 38:121-126.
16. Levesque E, Hoti E, Azoulay D, Ichai P, Habouchi H, Castaing D, et al. Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit. J Hepatol 2011; 56:95-102.
17. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004; 40:652-659.
18. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC,Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646-649.
19. Kamath PS,Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464-470.
20. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359:1018-1026.
21. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies. J Hepatol 2006; 44:217-231.
22. Vincent JL, De Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study. Working group on 'sepsis-related problems' of the European Society of Intensive Care Medicine. Crit Care Med 1998; 26:1793-1800.
23. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957-2963.
24. Moreno R, Vincent JL, Matos R, Mendonca A, Cantraine F, Thijs L, et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study Working Group on Sepsis related Problems of the ESICM. Intensive Care Med 1999; 25:686-696.
25. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et a.l. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-1256.
26. Knaus WA, Zimmerman JE, Wagner DP, Draper EA, Lawrence DE. APACHE-acute physiology and chronic health evaluation: A physiologically based classification system. Crit Care Med 1981; 9:591-597.
27. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40:373-383.
28. Cholongitas E, Senzolo M, Patch D, Kwong K, Nikolopoulou V, Leandro G, et al. Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther 2006; 23:883-893.
29. Kress JP, Rubin A, Pohlman AS, Hall JB. Outcomes of critically ill patients denied consideration for liver transplantation. Am J Respir Crit Care Med 2000; 162:418-423.
30. Tsai MH, Chen YC, Ho YP, Fang JT, Lien JM, Chiu CT, et al. Organ system failure scoring system can predict hospital mortality in critically ill cirrhotic patients. J Clin Gastroenterol 2003; 37:251-257.
31. Singh N, Gayowski T, Wagener MM, Marino IR. Outcome of patients with cirrhosis requiring intensive care unit support: Prospective assessment of predictors of mortality. J Gastroenterol 1998; 33:73-79.
32. Chen YC, Tsai MH, Ho YP, Hsu CW, Lin HH, Fang JT, et al. Comparison of the severity of illness scoring systems for critically ill cirrhotic patients with renal failure. Clin Nephrol 2004; 61:111-118.
33. Zauner CA, Apsner RC, Kranz A, Kramer L, Madl C, Schneider B, et al. Outcome prediction for patients with cirrhosis of the liver in a medical ICU: A comparison of the APACHE scores and liver-specific scoring systems. Intensive Care Med 1996; 22:559-563.
34. Ho YP, Chen YC, Yang C, Lien JM, Chu YY, Fang JT, et al. Outcome prediction for critically ill cirrhotic patients: A comparison of APACHE II and Child-Pugh scoring systems. J Intensive Care Med 2004; 19:105-110.
35. Cholongitas E, Senzolo M, Patch D, Shaw S, Hui C, Burroughs AK. Review article: Scoring systems for assessing prognosis in critically ill adult cirrhotics. Aliment Pharmacol Ther 2006; 24:453-464.
36. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146-155.
37. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377.
38. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008; 34:17-60.
39. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B. Current epidemiology of septic shock: The CUB-Rea Network. Am J Respir Crit Care Med 2003; 168:165-172.
40. Castellanos-Ortega A, Suberviola B, Garcia-Astudillo LA, Holanda MS, Ortiz F, Llorca J, et al. Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: Results of a three-year follow-up quasi-experimental study. Crit Care Med 2010; 38:1036-1043.
41. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-1308.
42. Kallet RH, Jasmer RM, Pittet JF, Tang JF, Campbell AR, Dicker R, et al. Clinical implementation of the ARDS network protocol is associated with reduced hospital mortality compared with historical controls. Crit Care Med 2005; 33:925-929.
43. Gustot T, Durand F, Lebrec D, Vincent JL, Moreau R. Severe sepsis in cirrhosis. Hepatology 2009; 50:2022-2033.
44. Bernard B, Grange JD, Khac EN, Amiot X, Opolon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta-analysis. Hepatology 1999; 29: 1655-1661.
45. Hou MC, Lin HC, Liu TT, Kuo BI, Lee FY, Chang FY, et al. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: A randomized trial. Hepatology 2004; 39:746-753.
46. Abraldes JG, Bosch J. Somatostatin and analogues in portal hypertension. Hepatology 2002; 35:1305-1312.
47. Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341:403-409.
48. Moreau R, Durand F, Poynard T, Duhamel C, Cervoni JP, Ichai P, et al. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: A retrospective multicenter study. Gastroenterology 2002; 122: 923-930.